Toggle navigation
Home
Search
Services
Blog
Contact
About
Detection of Mutations in Human P53, MSH2 and MLH1 Genes
Gingeras, Thomas Raymond
Affymetrix, Inc., Santa Clara, CA, United States
Search 34 grants from Thomas Gingeras
Search grants from Affymetrix, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Translational Studies of Paracrine CV Gene Transfer
Using Technology to Prevent HIV in Indian Wine Shops
Pharmacokinetics And Pharmacodynamics Of Drugs Of Abuse
RE-AIM Evaluation of Tailored Smoking Harm Reduction
Personality Traits as Semantic Categories
Recently added grants:
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges
Mechanistic clinical trial of individualized tDCS for hallucinations in schizophrenia
Multi-modal imaging of the mechanisms underlying impaired executive attention after traumatic brain injury
Molecular imaging of brain injury and repair in NFL players
Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease Heterogeneity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA067604-02
Application #
2111338
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (21))
Project Start
1996-03-15
Project End
1998-02-28
Budget Start
1996-03-15
Budget End
1997-02-28
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Affymetrix, Inc.
Department
Type
DUNS #
804682573
City
Santa Clara
State
CA
Country
United States
Zip Code
95051
Related projects
NIH 1997
R44 CA
Detection of Mutations in Human P53, MSH2 and MLH1 Genes
Gingeras, Thomas Raymond / Affymetrix, Inc.
NIH 1996
R44 CA
Detection of Mutations in Human P53, MSH2 and MLH1 Genes
Gingeras, Thomas Raymond / Affymetrix, Inc.
Comments
Be the first to comment on Thomas Gingeras's grant